Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy, ...

This article was reviewed by Darragh O’Carroll, MD. GLP-1 for Weight Loss: Everything You Need to Know Key takeaways: GLP-1s ...

Wegovy-maker Novo Nordisk presented new data on Wednesday showing its experimental weight-loss pill improved blood sugar ...

The Most Effective Appetite Suppressant OTC Natural hunger suppressant Diet Pills Read Benefits, Ingredients, Side Effects & How To Use?

Participants in a multidisciplinary comprehensive obesity care model had clinically meaningful weight loss and high obesity ...

Unregulated compounded GLP-1s are not the same as the legitimate medications that doctors prescribe for weight loss and chronic disease management.

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

The Trump administration is reportedly finalizing a deal with Eli Lilly and Novo Nordisk that would lower prices on Wegovy, ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that purpose ...

A once-daily oral nonpeptide GLP-1 conferred significant improvements in body weight, HbA1c and other cardiometabolic ...

The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...